Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Influenza Drugs and Vaccines Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Influenza Drugs and Vaccines Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Zanamivir
      • 1.3.3 Oseltamivir Phosphate
      • 1.3.4 Peramivir
      • 1.3.5 Trivalent
      • 1.3.6 Quadrivalent
    • 1.4 Market Segment by Application
      • 1.4.1 Global Influenza Drugs and Vaccines Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Research Laboratories
      • 1.4.4 Pharmacies
      • 1.4.5 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Influenza Drugs and Vaccines Market Size
      • 2.1.1 Global Influenza Drugs and Vaccines Revenue 2014-2025
      • 2.1.2 Global Influenza Drugs and Vaccines Sales 2014-2025
    • 2.2 Influenza Drugs and Vaccines Growth Rate by Regions
      • 2.2.1 Global Influenza Drugs and Vaccines Sales by Regions 2014-2019
      • 2.2.2 Global Influenza Drugs and Vaccines Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Influenza Drugs and Vaccines Sales by Manufacturers
      • 3.1.1 Influenza Drugs and Vaccines Sales by Manufacturers 2014-2019
      • 3.1.2 Influenza Drugs and Vaccines Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Influenza Drugs and Vaccines Revenue by Manufacturers (2014-2019)
      • 3.2.2 Influenza Drugs and Vaccines Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Influenza Drugs and Vaccines Market Concentration Ratio (CR5 and HHI)
    • 3.3 Influenza Drugs and Vaccines Price by Manufacturers
    • 3.4 Key Manufacturers Influenza Drugs and Vaccines Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Influenza Drugs and Vaccines Market
    • 3.6 Key Manufacturers Influenza Drugs and Vaccines Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Zanamivir Sales and Revenue (2014-2019)
      • 4.1.2 Oseltamivir Phosphate Sales and Revenue (2014-2019)
      • 4.1.3 Peramivir Sales and Revenue (2014-2019)
      • 4.1.4 Trivalent Sales and Revenue (2014-2019)
      • 4.1.5 Quadrivalent Sales and Revenue (2014-2019)
    • 4.2 Global Influenza Drugs and Vaccines Sales Market Share by Type
    • 4.3 Global Influenza Drugs and Vaccines Revenue Market Share by Type
    • 4.4 Influenza Drugs and Vaccines Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Influenza Drugs and Vaccines Sales by Application

    6 United States

    • 6.1 United States Influenza Drugs and Vaccines Breakdown Data by Company
    • 6.2 United States Influenza Drugs and Vaccines Breakdown Data by Type
    • 6.3 United States Influenza Drugs and Vaccines Breakdown Data by Application

    7 European Union

    • 7.1 European Union Influenza Drugs and Vaccines Breakdown Data by Company
    • 7.2 European Union Influenza Drugs and Vaccines Breakdown Data by Type
    • 7.3 European Union Influenza Drugs and Vaccines Breakdown Data by Application

    8 China

    • 8.1 China Influenza Drugs and Vaccines Breakdown Data by Company
    • 8.2 China Influenza Drugs and Vaccines Breakdown Data by Type
    • 8.3 China Influenza Drugs and Vaccines Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Influenza Drugs and Vaccines Breakdown Data by Company
    • 9.2 Rest of World Influenza Drugs and Vaccines Breakdown Data by Type
    • 9.3 Rest of World Influenza Drugs and Vaccines Breakdown Data by Application
    • 9.4 Rest of World Influenza Drugs and Vaccines Breakdown Data by Countries
      • 9.4.1 Rest of World Influenza Drugs and Vaccines Sales by Countries
      • 9.4.2 Rest of World Influenza Drugs and Vaccines Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 GlaxoSmithKline
      • 10.1.1 GlaxoSmithKline Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Influenza Drugs and Vaccines
      • 10.1.4 Influenza Drugs and Vaccines Product Introduction
      • 10.1.5 GlaxoSmithKline Recent Development
    • 10.2 Sanofi Pasteur, Inc.
      • 10.2.1 Sanofi Pasteur, Inc. Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Influenza Drugs and Vaccines
      • 10.2.4 Influenza Drugs and Vaccines Product Introduction
      • 10.2.5 Sanofi Pasteur, Inc. Recent Development
    • 10.3 CSL Limited
      • 10.3.1 CSL Limited Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Influenza Drugs and Vaccines
      • 10.3.4 Influenza Drugs and Vaccines Product Introduction
      • 10.3.5 CSL Limited Recent Development
    • 10.4 Astrazeneca
      • 10.4.1 Astrazeneca Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Influenza Drugs and Vaccines
      • 10.4.4 Influenza Drugs and Vaccines Product Introduction
      • 10.4.5 Astrazeneca Recent Development
    • 10.5 Protein Sciences Corporation
      • 10.5.1 Protein Sciences Corporation Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Influenza Drugs and Vaccines
      • 10.5.4 Influenza Drugs and Vaccines Product Introduction
      • 10.5.5 Protein Sciences Corporation Recent Development
    • 10.6 Serum Institute Of India Pvt. Ltd.
      • 10.6.1 Serum Institute Of India Pvt. Ltd. Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Influenza Drugs and Vaccines
      • 10.6.4 Influenza Drugs and Vaccines Product Introduction
      • 10.6.5 Serum Institute Of India Pvt. Ltd. Recent Development
    • 10.7 Emergent Biosolutions
      • 10.7.1 Emergent Biosolutions Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Influenza Drugs and Vaccines
      • 10.7.4 Influenza Drugs and Vaccines Product Introduction
      • 10.7.5 Emergent Biosolutions Recent Development
    • 10.8 Emergent Biosolutions
      • 10.8.1 Emergent Biosolutions Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Influenza Drugs and Vaccines
      • 10.8.4 Influenza Drugs and Vaccines Product Introduction
      • 10.8.5 Emergent Biosolutions Recent Development
    • 10.9 BioCryst Pharmaceuticals.Inc.
      • 10.9.1 BioCryst Pharmaceuticals.Inc. Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Influenza Drugs and Vaccines
      • 10.9.4 Influenza Drugs and Vaccines Product Introduction
      • 10.9.5 BioCryst Pharmaceuticals.Inc. Recent Development
    • 10.10 Alvogen
      • 10.10.1 Alvogen Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Influenza Drugs and Vaccines
      • 10.10.4 Influenza Drugs and Vaccines Product Introduction
      • 10.10.5 Alvogen Recent Development
    • 10.11 ABPI

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Influenza Drugs and Vaccines Sales Channels
      • 11.2.2 Influenza Drugs and Vaccines Distributors
    • 11.3 Influenza Drugs and Vaccines Customers

    12 Market Forecast

    • 12.1 Global Influenza Drugs and Vaccines Sales and Revenue Forecast 2019-2025
    • 12.2 Global Influenza Drugs and Vaccines Sales Forecast by Type
    • 12.3 Global Influenza Drugs and Vaccines Sales Forecast by Application
    • 12.4 Influenza Drugs and Vaccines Forecast by Regions
      • 12.4.1 Global Influenza Drugs and Vaccines Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Influenza Drugs and Vaccines Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Influenza Drugs and Vaccines is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Influenza Drugs and Vaccines.

      This report studies the global market size of Influenza Drugs and Vaccines, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Influenza Drugs and Vaccines sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      GlaxoSmithKline
      Sanofi Pasteur, Inc.
      CSL Limited
      Astrazeneca
      Protein Sciences Corporation
      Serum Institute Of India Pvt. Ltd.
      Emergent Biosolutions
      Emergent Biosolutions
      BioCryst Pharmaceuticals.Inc.
      Alvogen
      ABPI

      Market Segment by Product Type
      Zanamivir
      Oseltamivir Phosphate
      Peramivir
      Trivalent
      Quadrivalent

      Market Segment by Application
      Hospitals
      Research Laboratories
      Pharmacies
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Influenza Drugs and Vaccines status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Influenza Drugs and Vaccines manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Influenza Drugs and Vaccines are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now